> top > projects > sentences > docs > PubMed:17919354 > annotations
sentences Home  

PubMed:17919354 JSONTXT 13 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-82 Sentence denotes Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer.
T1 0-82 Sentence denotes Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer.
TextSentencer_T2 83-226 Sentence denotes Porphyria cutanea tarda (PCT) is sometimes precipitated or aggravated by increased exposure to estrogen, estrogen-like compounds, or tamoxifen.
T2 83-226 Sentence denotes Porphyria cutanea tarda (PCT) is sometimes precipitated or aggravated by increased exposure to estrogen, estrogen-like compounds, or tamoxifen.
TextSentencer_T3 227-350 Sentence denotes We report the case of a 37-year-old white woman who developed sporadic PCT after she took oral contraceptives for 10 years.
T3 227-350 Sentence denotes We report the case of a 37-year-old white woman who developed sporadic PCT after she took oral contraceptives for 10 years.
TextSentencer_T4 351-444 Sentence denotes She was heterozygous for the common H63D mutation of the hemochromatosis-associated HFE gene.
T4 351-444 Sentence denotes She was heterozygous for the common H63D mutation of the hemochromatosis-associated HFE gene.
TextSentencer_T5 445-688 Sentence denotes The PCT responded partially to the cessation of oral contraceptives and to phlebotomy therapy to maintain low iron stores, but only remitted after she received anastrozole therapy for management of adenocarcinoma of the breast at age 59 years.
T5 445-688 Sentence denotes The PCT responded partially to the cessation of oral contraceptives and to phlebotomy therapy to maintain low iron stores, but only remitted after she received anastrozole therapy for management of adenocarcinoma of the breast at age 59 years.
TextSentencer_T6 689-858 Sentence denotes The pertinence of HFE mutations, anastrozole and tamoxifen treatment, and chemotherapy to the development and management of PCT in women with breast cancer is discussed.
T6 689-858 Sentence denotes The pertinence of HFE mutations, anastrozole and tamoxifen treatment, and chemotherapy to the development and management of PCT in women with breast cancer is discussed.